flucytosine has been researched along with Experimental Mammary Neoplasms in 3 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Ye, T | 1 |
| Maynard, J | 1 |
| Akbulut, H | 1 |
| Deisseroth, A | 1 |
| Fox, ME | 1 |
| Lemmon, MJ | 1 |
| Mauchline, ML | 1 |
| Davis, TO | 1 |
| Giaccia, AJ | 1 |
| Minton, NP | 1 |
| Brown, JM | 1 |
| Kammertoens, T | 1 |
| Gelbmann, W | 1 |
| Karle, P | 1 |
| Alton, K | 1 |
| Saller, R | 1 |
| Salmons, B | 1 |
| Günzburg, WH | 1 |
| Uckert, W | 1 |
3 other studies available for flucytosine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy.
Topics: Adenoviridae; Adenovirus E1A Proteins; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; C | 2006 |
Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.
Topics: Animals; Antimetabolites, Antineoplastic; Base Sequence; Carcinoma; Cell Survival; Cloning, Molecula | 1996 |
Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.
Topics: Animals; Cats; Cell Line; Cell Transplantation; Cytochrome P-450 CYP2B1; Cytosine Deaminase; Female; | 2000 |